Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-069349
Filing Date
2025-05-12
Accepted
2025-05-12 16:42:00
Documents
2
Period of Report
2025-05-12

Document Format Files

Seq Description Document Type Size
1 6-K clls_6-k_q1_2025.htm 6-K 29857
2 EX-99.1 clls-ex99_1.htm EX-99.1 2990209
  Complete submission text file 0000950170-25-069349.txt   3021119
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36891 | Film No.: 25935556
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)